| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:44.)
© 2005 American Heart Association, Inc.
Original Contributions |
From the HUS Helsinki Medical Imaging Center (J.P., S.M., O.S., S.S., H.J.A.), University of Helsinki, Helsinki, Finland; the Department of Child Neurology (J.P.), Helsinki University Central Hospital, Helsinki, Finland; the Department of Physical Sciences (J.P., S.S.), University of Helsinki, Helsinki, Finland; the Department of Neurology (L.S., J.H., M.K., T.T.), Helsinki University Central Hospital, Helsinki, Finland; the Department of Neuroradiology (L.Ø.), Center for Functionally Integrative Neuroscience, Aarhus University Hospital, Aarhus, Denmark; HUSLAB (A.K., S.S.), Department of Clinical Physiology & Nuclear Medicine, University of Helsinki, Helsinki, Finland; and the Functional Brain Imaging Unit (J.B., S.M., O.S., H.J.A.), Helsinki Brain Research Center, Helsinki, Finland.
Correspondence to Jussi Perkiö, MSc, Department of Child Neurology, Hospital for Children and Adolescents, Helsinki University Central Hospital, Lastenlinnantie 2, FIN-00290 Helsinki, Finland. E-mail jussi.perkio{at}hus.fi
Background and Purpose The determination of cerebral blood flow heterogeneity (FH) by dynamic susceptibility contrast (DSC) magnetic resonance imaging has recently been proposed as a tool to predict final infarct size in acute stroke. In this study, we describe the evolution of FH during the first week as well as its correlation to the patients clinical status.
Methods Ten patients with ischemic stroke were studied with DSC MRI and diffusion-weighted imaging in hyperacute (<6 hours) phase, at 24 hours, and 1 week after symptom onset. In addition to intravoxel FH, cerebral blood volume (CBV), cerebral blood flow (CBF), and contrast agent mean transit time (MTT) were determined from DSC MRI. All patients were evaluated neurologically with National Institute of Health Stroke Scale concurrently with the imaging sessions.
Results All patients showed infarct growth, judged by diffusion-weighted imaging, during the week with simultaneous decrease in the sizes of FH, CBV, CBF, and MTT abnormalities. The FH abnormality was shown to be larger than CBV and CBF abnormalities at the hyperacute phase and 24 hours, but smaller than MTT abnormality in all 3 imaging sessions. The sizes of hyperacute FH, CBV, CBF, and MTT abnormalities correlated well with infarct size at 24 hours and at 1 week. Additionally, FH was the only perfusion parameter that correlated with the clinical score.
Conclusions FH predicts infarct size equally well with the other perfusion parameters but is superior in correlation with the clinical score. FH can easily be incorporated to hyperacute stroke imaging without additional efforts.
Key Words: magnetic resonance imaging perfusion stroke
This article has been cited by other articles:
![]() |
J.M. Provenzale, K. Shah, U. Patel, and D.C. McCrory Systematic Review of CT and MR Perfusion Imaging for Assessment of Acute Cerebrovascular Disease AJNR Am. J. Neuroradiol., September 1, 2008; 29(8): 1476 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zhao, S. Amin-Hanjani, S. Ruland, A.P. Curcio, L. Ostergren, and F.T. Charbel Regional Cerebral Blood Flow Using Quantitative MR Angiography AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1470 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. McKhann, M. A. Grega, L. M. Borowicz Jr, W. A. Baumgartner, and O. A. Selnes Stroke and Encephalopathy After Cardiac Surgery: An Update Stroke, February 1, 2006; 37(2): 562 - 571. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |